aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Genoa Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for idiopathic pulmonary fibrosis (IPF). Their mission is to improve the lives of patients suffering from this debilitating lung disease through advanced treatment options. Genoa Pharmaceuticals aims to address the unmet medical needs in the IPF market with cutting-edge research and development.
Genoa Pharmaceuticals has made significant strides in the field of pulmonary medicine, contributing to the advancement of IPF treatments. Their work has garnered attention within the medical community, positioning them as a key player in biopharmaceutical innovation.
Operating Status
Acquired
Ownership Type(s)
Private
Main Product(s)
Therapies
Technology
Biotech
Model Types
Licensing, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Genoa Pharmaceuticals founded?
Genoa Pharmaceuticals was founded in 2011.
Where is Genoa Pharmaceuticals’s headquarters located?
Genoa Pharmaceuticals’s headquarters is located in San Diego, CA, US.
When was Genoa Pharmaceuticals’s last funding round?
Genoa Pharmaceuticals’s most recent funding round was for $62M (USD) in May 2017.
How many employees does Genoa Pharmaceuticals have?
Genoa Pharmaceuticals has 10 employees as of Feb 4, 2024.
How much has Genoa Pharmaceuticals raised to-date?
As of July 05, 2023, Genoa Pharmaceuticals has raised a total of $64.2M (USD) since May 15, 2017.
Add Comparison
Total Raised to Date
$64.2M
USD
Last Update May 15, 2017
Last Deal Details
$62M
USD
May 15, 2017
Series A
Total Employees Over Time
10
As of Feb 2024
Genoa Pharmaceuticals Address
12636 High Bluff Drive
suite 400
San Diego,
California
92130
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts